长期新冠（long Covid）的关键困境在于：流行率、诊断与治疗证据都高度混乱。文中提到，不同研究估计盛行率差异极大，从英国人口的3.3%到南美洲的51%、埃及的86%不等；而BMJ系统回顾仅将认知行为治疗与运动列为「中等证据」支持，但会议上专家反而多次警告避免运动，并否定CBT。六年来、近20亿美元与半个世纪式的国际投入后，仍没有核准药物、也没有可验证的检测，主流研究只留下微血栓、刺突蛋白与粒线体失调等假说。
作者以Andrew Larson等重症患者说明，长期新冠常被误诊、被质疑，甚至被送进精神科；而标准检查往往显示「正常」。相对地，Becca Kennedy与Howard Schubiner等脑重训疗法支持者主张，症状源自大脑卡在战或逃回路，透过呼吸、身体觉察、创伤治疗与认知练习可重训神经系统。文中列举个案显示，Larson在低剂量纳曲酮后能走到每日1,000步，Giorgia Lupi在Dynamic Neural Retraining System后疼痛与食物不耐受大幅缓解，显示部分患者确有改善，但证据主要来自个案、见证与小型研究。
本文最核心的统计与方法争议，是「定义太宽」与「过度禁止运动」如何扭曲科学。NASEM在2024年采用刻意包容的定义：感染后至少3个月、只要有一项症状即可，且不必有阳性检测；这虽有助于承认病人痛苦，却会增加资料杂讯。相较之下，ME/CFS曾因PACE试验引发强烈反弹，患者调查显示74%的人认为运动治疗让他们更糟。作者最后主张，心理与生理并非非黑即白；真正的问题是恐惧、污名、保险压力与政治化争论，使研究者难以公平检验脑身介入，也让病人继续在「真正生物性」与「全在脑中」的假二分里受苦，结果是没有人真正得到帮助。
Long Covid remains scientifically chaotic: prevalence estimates vary wildly from 3.3% in the UK to 51% in South America and 86% in Egypt, while the BMJ review cites only moderate evidence for CBT and exercise, yet conference experts often warn against exercise and reject CBT. After roughly $2 billion and six years of work, there is still no approved drug and no diagnostic test, only competing hypotheses involving microclots, spike proteins, and mitochondrial dysfunction.
The article contrasts mainstream uncertainty with mind-body clinicians such as Becca Kennedy and Howard Schubiner, who argue that symptoms can arise from a brain-based fight-or-flight loop. Case reports are striking: Andrew Larson improved enough to walk 1,000 steps a day, and Giorgia Lupi’s pain and food intolerances eased after Dynamic Neural Retraining System work. But these accounts are largely anecdotal, and the evidence base is still built on small studies, testimonials, and contested interpretation.
The central methodological dispute is whether definitions and trial design are too broad or too narrow. In 2024, NASEM adopted an intentionally inclusive definition: at least three months of illness after SARS-CoV-2 infection, with just one symptom required and no prior positive test necessary. Critics say that broadness increases noise and weakens research, much like the backlash to the PACE trial in ME/CFS, where 74% of surveyed patients said exercise therapy made them worse. The author concludes that stigma, fear, and false body-versus-mind binaries prevent impartial research and keep many patients from getting effective help.